Knowledge Hub

Human Biobanking Ownership - Market To Witness a value of US$37.1 billion by 2020

Press Release   •   Feb 24, 2017 02:14 EST

Global Market Watch:

Primarily supported by ownership types; Private Biobanks and Public Biobanks (Disease-Based Banks, Population-Based Banks and Academics) market is to witness a value of US$37.1 billion by 2020. Geographical analysis for Private Biobanks shows the highest Compounded Annual Growth Rate (CAGR) of 10.75% is foreseen from Asia-Pacific region during the analysis period 2014-2020. North America is not way behind with a CAGR of 9.95% followed by Europe at 9.56% respectively.

Report Focus:

The report “Human Biobanking Ownership - Global Trends, Estimates and Forecasts, 2014-2020” reviews the latest human biobanking market trends with a perceptive attempt to disclose the near-future growth prospects. An in-depth analysis on a geographic basis provides strategic business intelligence for life science sector investments. The study reveals profitable investment strategies for pharmaceutical manufacturers, biotechnology companies, laboratories, Contract Research Organizations (CROs) and many more in preferred locations. The report primarily focuses on:

  • Emerging market trends
  • Advancements in the technological space
  • Market demand of the segments (by-region)
  • Key growth areas and market size
  • Key competitor’s Edge

Estimates are based on online surveys using customized questionnaires by our research team. Besides information from government databases, company websites, press releases & published research reports are also used for estimates.

The analysis primarily deals with human biobanking ownership market. Further, the subdivided categories include:

  • Private Banks
    • a. Disease-Based Banks
    • b. Population-Based Banks
    • c. Academics
  • Public Banks1
    • a. Disease-Based Banks
    • b. Population-Based Banks
    • c. Academics
  • Hospitals, Biotechnology & Pharmaceutical Companies, Diagnostics, Transplantation and Biobank Storage Companies
  • Newborns, Adults or Pregnant Women
  • Medical Institutions, Research and Forensics

The period considered for the human biobanking ownership market analysis is 2014-2020. The region wise distribution of the market consists of North America (USA, Canada and Mexico), Europe (United Kingdom, Germany, France, Spain, Italy, The Netherlands, Switzerland, Russia and Rest of Europe), Asia-Pacific (China, Japan, India, South Korea and Rest of Asia-Pacific) and Rest of the World (Brazil, Middle East, South Africa, Rest of Latin America and Rest of Africa). The market growth rate in the major economies such as the U.S., Japan, China etc. are estimated individually for the upcoming years.

More than 1270 leading market players are identified and 107 key companies that project improved market activities in the near future are profiled. The report consists of 138 data charts describing the market shares, sales forecasts and growth prospects. Moreover, key strategic activities in the market including mergers/acquisitions, collaborations/partnerships, product launches/developments are discussed.

Download Sample Copy of Report at

List of Key Companies

North America

  • Vericel Corporation
  • Acorda Therapeutics, Inc.
  • Alpha Cord, Inc.
  • Affymetrix, Inc.
  • Cellerant Therapeutics, Inc.
  • Cryo-Cell International, Inc.
  • Mesoblast, Inc.
  • Atgc Labs
  • Autogen, Inc.
  • Barber Nichols
  • Beckman Coulter, Inc.
  • Biocision
  • U.S. Stem Cell, Inc.
  • Biolife Solutions, Inc.
  • Biological Specimen Inventory System
  • Biomatrica, Inc.
  • Biostorage, Llc.
  • Cti Biopharma Corp.
  • Chart Industries, Inc.
  • Charter Medical, Ltd.
  • Corcell, Inc.
  • Cord Blood Registry
  • Core Dynamics (Usa), Inc.
  • Cryolife, Inc.
  • Cryomagnetics, Inc.
  • Cryoplus, Inc.
  • Cryoxtract
  • Custom Biogenic Systems
  • Dataworks Development, Inc.
  • Dna Genotek, Inc.
  • Epl Archieves, Inc.
  • Genzyme Corp.
  • Gilead Sciences, Inc.
  • Hamilton Storage Technologies
  • Labvantage Solutions, Inc.
  • Labware, Inc.
  • Lifenet Health
  • Caladrius Biosciences, Inc.
  • Eppendorf, Inc.
  • Novare Biologistics
  • Origen Biomedical, Inc.
  • Osiris Therapeutics, Inc.
  • Pacific Bio-Material Management, Inc.
  • Promeddx, Llc
  • Provia Laboratories, Llc
  • Qiagen Nv
  • Rand Corporation
  • Ruro
  • Seracare Life Sciences
  • Scientific Instruments, Inc.
  • Sp Scientific
  • Spectrocell, Inc.
  • Abbott Laboratories
  • Steelgate, Inc.
  • Trillium Therapeutics, Inc.
  • Stem Cells, Inc.
  • Stemcell Technologies, Inc.
  • Lifeline® Cell Technology
  • Thermo Fisher Scientific, Inc.
  • Cesca Therapeutics, Inc.
  • Trans-Hit Biomarkers, Inc.
  • Vaisala, Inc.
  • Viacord
  • Vital Therapies, Inc.
  • Wheaton Science Products, Inc.


  • Panasonic Biomedical Sales Europe B.V
  • Epistem Ltd.
  • Aqix
  • B & C Group
  • Bbmri
  • Lifegene
  • Biobank Ireland Trust
  • Biokryo Gmbh
  • Biorep Srl P.Iva
  • Biostorage Technologies, Inc.
  • Boehringer Ingelheim, Gmbh
  • Cells4life, Ltd.
  • Cryo Bio System
  • Cryo-Save, Ag
  • Decode Genetics
  • Ge Healthcare Life Sciences
  • Genesisbps
  • Highres Biosolutions
  • Indivumed
  • Lifegene Biobank
  • Lifelines Cohort And Biobank (Lifelines)
  • Linde Gas Cryoservices B.V.
  • Modul-Bio Sas
  • Mts Cryostores Uk Ltd
  • Noray Bioinformatics S.L.U.
  • Reneuron Group Plc
  • Sanofi Aventis
  • Soventec Gmbh
  • Stirling Cryogenics & Refrigeration Bv
  • Tecan
  • Tissue Solutions
  • UK Stem Cell Bank


  • Cole Parmer Instrument, Co.
  • Cordlife Pte., Ltd.
  • Cryocord Sdn.Bhd.
  • Cryologic Pty. Ltd.
  • Genesearch
  • Ocimum Biosolutions
  • Reliance Life Sciences
  • China Cord Blood Corporation

Rest of World

  • Babycell Egypt
  • Gamida Cell Ltd.